No prognostic role of a GWAS-derived genetic risk score in renal outcomes for patients from French cohorts with type 1 and type 2 diabetes
P. Barbieux(Centre Hospitalier Universitaire de Poitiers), Samy Hadjadj(Université de Poitiers), Pierre‐Jean Saulnier(Inserm), Grégory Ducrocq, Stéphanie Ragot(Université de Tours), Vincent Rigalleau(Université de Bordeaux), Elise Gand(Université de Poitiers), P Zaoui(Centre Hospitalier Universitaire de Grenoble), P. Llaty(Université de Poitiers), Ronan Roussel(Lyon 1 Université), David Montaigne(Centre Hospitalier Universitaire de Lille), Jean‐Michel Halimi(Centre Hospitalier Universitaire de Tours), David‐Alexandre Trégouët(Université de Bordeaux), Eva Feigerlová(Inserm), Beata Gyorgy(Inserm), P. Sosner(Inserm), Michel Marre(Centre National de la Recherche Scientifique), C. Hulin-Delmotte(Université de Poitiers)
Cited by 10
Related Papers
Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
|New England Journal of Medicine|2008|7.4k
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
|European Heart Journal|2012|6.8k
Association of Cardiometabolic Multimorbidity With Mortality
|JAMA|2015|1.2k
PPAR control of metabolism and cardiovascular functions
|Nature Reviews Cardiology|2021|901
Follow-up of Blood-Pressure Lowering and Glucose Control in Type 2 Diabetes
|New England Journal of Medicine|2014|624